MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsMediumNeutral
Announced Thu, 16 Oct · 16:40 IST

Mangalam Drugs And Organics Limited has informed the Exchange about Scheme of Arrangement

Nclt Scheme FiledStrategic Transactions View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mangalam Drugs and Organics Limited has informed the stock exchange about a Scheme of Arrangement, which is a formal corporate restructuring plan. No specific details about the type of scheme (merger, demerger, spin-off, capital reduction, etc.), counterparty, share exchange ratio, or valuation have been disclosed in this filing. Such schemes are typically filed before the National Company Law Tribunal (NCLT) for approval. Shareholders and creditors will get a chance to vote on the proposal once detailed documents are filed. The actual impact on the company's structure and shareholder value will depend on the terms yet to be shared.

Likely market impact

Schemes of Arrangement can lead to significant corporate restructuring, potentially affecting shareholding patterns, business focus, or capital structure. Until full details are disclosed, investors should watch for further filings to understand the implications for their holdings.